Harvard Bioscience Inc (HBIO)

NASD · Healthcare · Medical Instruments & Supplies · USA

Harvard Bioscience Inc is a micro cap company (market value under $300 million) in the Medical Instruments & Supplies industry.

Harvard Bioscience creates and distributes equipment, software and related services for life science research, pharmaceutical discovery, therapeutic production and safety testing. The company serves academic institutions, government laboratories, pharmaceutical and biotechnology firms, and contract research organizations worldwide through direct sales and distributor networks across the United States, Europe and China.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Harvard Bioscience Inc stock.

Our verdict on HBIO

Not valued: We cannot value this company yet.

We do not publish a value for this company: not even its current assets cover what it owes.

ETFs with the most weight in HBIO

3 more funds hold it; the full list is part of the paid plan.

Browse

Peers in Medical Instruments & Supplies

All 52 Medical Instruments & Supplies stocks

Cheaper than HBIO in Medical Instruments & Supplies

23 more in this industry show a wider margin of safety.

Is HBIO undervalued or overvalued?

We do not publish a verdict on HBIO yet. We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.

What is the intrinsic value of HBIO?

We do not publish one (as of the 2026-11-17 close). We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.